[1] Rio E, Mornex F, Peiffert D, et al. Hepatic tumors and radiotherapy. Cancer Radiother,2016, 20:S174-178.
[2] Lee TY, Lin CC, Chen CY, et al. Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early-intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial. Medicine(baltimore),2017,96:e7655.
[3] Finn RS, Zhu AX, Farah W, et al. Therapies for advanced stage hepatocelluiar carcinoma with macrovascular invasion or metastic disease:a systematic review and meta-analysis. Hepatology,2018,67:422-435.
[4] Chen L, Zheng Y, Zhang H,et al. Comparative analysis of tumor-associated vascular changes following TACE alone or in combination with sorafenib treatment in HCC: A retrospective study. Oncol Lett,2018,16: 3690-3698. |
